Loading…
Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes
Carcinogenic aromatic amines, including the heterocyclic amines, may pose a significant health risk to humans. To determine the potential for chemoprotective intervention against the carcinogenicity of these arylamines and to better understand their mechanism of action, a range of agents, most of th...
Saved in:
Published in: | Nutrition and cancer 1999, Vol.33 (1), p.46-52 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33 |
---|---|
cites | cdi_FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33 |
container_end_page | 52 |
container_issue | 1 |
container_start_page | 46 |
container_title | Nutrition and cancer |
container_volume | 33 |
creator | Hammons, G.J Fletcher, J.V Stepps, K.R Smith, E.A Balentine, D.A Harbowy, M.E Kadlubar, F.F |
description | Carcinogenic aromatic amines, including the heterocyclic amines, may pose a significant health risk to humans. To determine the potential for chemoprotective intervention against the carcinogenicity of these arylamines and to better understand their mechanism of action, a range of agents, most of them natural dietary constituents, was examined in vitro for their ability to modulate the N-hydroxylation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 4-aminobiphenyl (ABP), an initial step in their bioactivation. Experiments were conducted with rat and human liver microsomes. The agents (diallyl sulfide, indole-3-carbinol, alpha-angelicalactone, cafestol/kahweol palmitates, cafestol, kahweol, benzylisothiocyanate, genistin, formononetin, daidzin, equol, biochanin A, Oltipraz, tannic acid, quercetin, ethoxyquin, green tea, and black tea) comprised a variety of chemical classes that included sulfur-containing compounds, antioxidants, flavonoids, phytoestrogens, diterpenes, and polyphenols. Several of these agents, quercetin, ethoxyquin, and black tea, were found to strongly inhibit PhIP N-hydroxylation in rat liver microsomes, resulting in a nearly 85-90% decrease in activity at 100 micromolar or 0.2%. Tannic acid and green tea, in addition to these agents, were also strong inhibitors of ABP N-hydroxylation. In human liver microsomes, each of these agents was strongly inhibitory (approx 85-95% at 100 micromolar or 0.02%) of PhIP and ABP N-hydroxylation. Theaflavins and polyphenols were judged to be the primary inhibiting components in the teas, the theaflavins showing the most potent effect. These results demonstrate that chemoprotective agents can inhibit the bioactivation of carcinogenic arylamines, and this is likely to be one of the mechanisms of protection. |
doi_str_mv | 10.1080/01635589909514747 |
format | article |
fullrecord | <record><control><sourceid>pubmed_fao_a</sourceid><recordid>TN_cdi_fao_agris_US201302935996</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10227043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33</originalsourceid><addsrcrecordid>eNqFkN9qFTEQh4Mo9lh9AG80F71dO_m3OQFvpFQtFFrQXi_ZbNKN7CaHJK2eJ-nrmu1WFAr1amB-3zfDDEJvCXwgsIVjIC0TYqsUKEG45PIZ2hDBaCMV4c_RZsmbCpAD9CrnHwAgCdu-RAcEKJXA2QbdnTpnTck4OmxGO8ddiqU2_K3F-tqGJQm4jBbPtug-Tt5gvcS6-BpUa8mMTsaHWPklTvtJzz7YjC_Hs0usw4B5s3Ri73ejDfsJ-4DHm1mH-zDpgqe6MOHZmxRznG1-jV44PWX75qEeoqvPp99PvjbnF1_OTj6dN4YLUhpHnTN2MG1rjLKWEKO0ECA5GCoGkALo1gxUcaeJklaB7Q0oxSnhjPU9Y4eIrHOXxTlZ1-2Sn-sJHYFueXL36MnVebc6u5t-tsM_xvrVChw9ADobPbmkg_H5LyfbVohljlwxH1xMs_4Z0zR0Re-nmP44j7Z35Vep5sf_muypA96vutOx09ep0lffKBAGVDGhVMt-AxVUtY8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Hammons, G.J ; Fletcher, J.V ; Stepps, K.R ; Smith, E.A ; Balentine, D.A ; Harbowy, M.E ; Kadlubar, F.F</creator><creatorcontrib>Hammons, G.J ; Fletcher, J.V ; Stepps, K.R ; Smith, E.A ; Balentine, D.A ; Harbowy, M.E ; Kadlubar, F.F</creatorcontrib><description>Carcinogenic aromatic amines, including the heterocyclic amines, may pose a significant health risk to humans. To determine the potential for chemoprotective intervention against the carcinogenicity of these arylamines and to better understand their mechanism of action, a range of agents, most of them natural dietary constituents, was examined in vitro for their ability to modulate the N-hydroxylation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 4-aminobiphenyl (ABP), an initial step in their bioactivation. Experiments were conducted with rat and human liver microsomes. The agents (diallyl sulfide, indole-3-carbinol, alpha-angelicalactone, cafestol/kahweol palmitates, cafestol, kahweol, benzylisothiocyanate, genistin, formononetin, daidzin, equol, biochanin A, Oltipraz, tannic acid, quercetin, ethoxyquin, green tea, and black tea) comprised a variety of chemical classes that included sulfur-containing compounds, antioxidants, flavonoids, phytoestrogens, diterpenes, and polyphenols. Several of these agents, quercetin, ethoxyquin, and black tea, were found to strongly inhibit PhIP N-hydroxylation in rat liver microsomes, resulting in a nearly 85-90% decrease in activity at 100 micromolar or 0.2%. Tannic acid and green tea, in addition to these agents, were also strong inhibitors of ABP N-hydroxylation. In human liver microsomes, each of these agents was strongly inhibitory (approx 85-95% at 100 micromolar or 0.02%) of PhIP and ABP N-hydroxylation. Theaflavins and polyphenols were judged to be the primary inhibiting components in the teas, the theaflavins showing the most potent effect. These results demonstrate that chemoprotective agents can inhibit the bioactivation of carcinogenic arylamines, and this is likely to be one of the mechanisms of protection.</description><identifier>ISSN: 0163-5581</identifier><identifier>EISSN: 1532-7914</identifier><identifier>DOI: 10.1080/01635589909514747</identifier><identifier>PMID: 10227043</identifier><identifier>CODEN: NUCADQ</identifier><language>eng</language><publisher>Philadelphia, PA: Taylor & Francis Group</publisher><subject>amines ; Aminobiphenyl Compounds - metabolism ; animal models ; Animals ; Anticarcinogenic Agents - pharmacology ; antineoplastic agents ; Antioxidants - pharmacology ; aromatic compounds ; Biological and medical sciences ; Carcinogenesis, carcinogens and anticarcinogens ; carcinogens ; Carcinogens - metabolism ; Diterpenes - pharmacology ; Estrogens, Non-Steroidal - pharmacology ; Flavonoids - pharmacology ; Foods and miscellaneous ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Imidazoles - metabolism ; inhibition ; Isoflavones ; liver ; Liver Neoplasms - chemically induced ; Liver Neoplasms - metabolism ; Liver Neoplasms - prevention & control ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; microsomes ; Microsomes, Liver - drug effects ; Microsomes, Liver - metabolism ; Phenols - pharmacology ; Phytoestrogens ; Plant Preparations ; Polymers - pharmacology ; Rats ; Rats, Inbred F344 ; Tumors</subject><ispartof>Nutrition and cancer, 1999, Vol.33 (1), p.46-52</ispartof><rights>Copyright Taylor & Francis Group, LLC 1999</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33</citedby><cites>FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1766557$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10227043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hammons, G.J</creatorcontrib><creatorcontrib>Fletcher, J.V</creatorcontrib><creatorcontrib>Stepps, K.R</creatorcontrib><creatorcontrib>Smith, E.A</creatorcontrib><creatorcontrib>Balentine, D.A</creatorcontrib><creatorcontrib>Harbowy, M.E</creatorcontrib><creatorcontrib>Kadlubar, F.F</creatorcontrib><title>Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes</title><title>Nutrition and cancer</title><addtitle>Nutr Cancer</addtitle><description>Carcinogenic aromatic amines, including the heterocyclic amines, may pose a significant health risk to humans. To determine the potential for chemoprotective intervention against the carcinogenicity of these arylamines and to better understand their mechanism of action, a range of agents, most of them natural dietary constituents, was examined in vitro for their ability to modulate the N-hydroxylation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 4-aminobiphenyl (ABP), an initial step in their bioactivation. Experiments were conducted with rat and human liver microsomes. The agents (diallyl sulfide, indole-3-carbinol, alpha-angelicalactone, cafestol/kahweol palmitates, cafestol, kahweol, benzylisothiocyanate, genistin, formononetin, daidzin, equol, biochanin A, Oltipraz, tannic acid, quercetin, ethoxyquin, green tea, and black tea) comprised a variety of chemical classes that included sulfur-containing compounds, antioxidants, flavonoids, phytoestrogens, diterpenes, and polyphenols. Several of these agents, quercetin, ethoxyquin, and black tea, were found to strongly inhibit PhIP N-hydroxylation in rat liver microsomes, resulting in a nearly 85-90% decrease in activity at 100 micromolar or 0.2%. Tannic acid and green tea, in addition to these agents, were also strong inhibitors of ABP N-hydroxylation. In human liver microsomes, each of these agents was strongly inhibitory (approx 85-95% at 100 micromolar or 0.02%) of PhIP and ABP N-hydroxylation. Theaflavins and polyphenols were judged to be the primary inhibiting components in the teas, the theaflavins showing the most potent effect. These results demonstrate that chemoprotective agents can inhibit the bioactivation of carcinogenic arylamines, and this is likely to be one of the mechanisms of protection.</description><subject>amines</subject><subject>Aminobiphenyl Compounds - metabolism</subject><subject>animal models</subject><subject>Animals</subject><subject>Anticarcinogenic Agents - pharmacology</subject><subject>antineoplastic agents</subject><subject>Antioxidants - pharmacology</subject><subject>aromatic compounds</subject><subject>Biological and medical sciences</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>carcinogens</subject><subject>Carcinogens - metabolism</subject><subject>Diterpenes - pharmacology</subject><subject>Estrogens, Non-Steroidal - pharmacology</subject><subject>Flavonoids - pharmacology</subject><subject>Foods and miscellaneous</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Imidazoles - metabolism</subject><subject>inhibition</subject><subject>Isoflavones</subject><subject>liver</subject><subject>Liver Neoplasms - chemically induced</subject><subject>Liver Neoplasms - metabolism</subject><subject>Liver Neoplasms - prevention & control</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>microsomes</subject><subject>Microsomes, Liver - drug effects</subject><subject>Microsomes, Liver - metabolism</subject><subject>Phenols - pharmacology</subject><subject>Phytoestrogens</subject><subject>Plant Preparations</subject><subject>Polymers - pharmacology</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Tumors</subject><issn>0163-5581</issn><issn>1532-7914</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkN9qFTEQh4Mo9lh9AG80F71dO_m3OQFvpFQtFFrQXi_ZbNKN7CaHJK2eJ-nrmu1WFAr1amB-3zfDDEJvCXwgsIVjIC0TYqsUKEG45PIZ2hDBaCMV4c_RZsmbCpAD9CrnHwAgCdu-RAcEKJXA2QbdnTpnTck4OmxGO8ddiqU2_K3F-tqGJQm4jBbPtug-Tt5gvcS6-BpUa8mMTsaHWPklTvtJzz7YjC_Hs0usw4B5s3Ri73ejDfsJ-4DHm1mH-zDpgqe6MOHZmxRznG1-jV44PWX75qEeoqvPp99PvjbnF1_OTj6dN4YLUhpHnTN2MG1rjLKWEKO0ECA5GCoGkALo1gxUcaeJklaB7Q0oxSnhjPU9Y4eIrHOXxTlZ1-2Sn-sJHYFueXL36MnVebc6u5t-tsM_xvrVChw9ADobPbmkg_H5LyfbVohljlwxH1xMs_4Z0zR0Re-nmP44j7Z35Vep5sf_muypA96vutOx09ep0lffKBAGVDGhVMt-AxVUtY8</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>Hammons, G.J</creator><creator>Fletcher, J.V</creator><creator>Stepps, K.R</creator><creator>Smith, E.A</creator><creator>Balentine, D.A</creator><creator>Harbowy, M.E</creator><creator>Kadlubar, F.F</creator><general>Taylor & Francis Group</general><general>Taylor& Francis</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1999</creationdate><title>Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes</title><author>Hammons, G.J ; Fletcher, J.V ; Stepps, K.R ; Smith, E.A ; Balentine, D.A ; Harbowy, M.E ; Kadlubar, F.F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>amines</topic><topic>Aminobiphenyl Compounds - metabolism</topic><topic>animal models</topic><topic>Animals</topic><topic>Anticarcinogenic Agents - pharmacology</topic><topic>antineoplastic agents</topic><topic>Antioxidants - pharmacology</topic><topic>aromatic compounds</topic><topic>Biological and medical sciences</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>carcinogens</topic><topic>Carcinogens - metabolism</topic><topic>Diterpenes - pharmacology</topic><topic>Estrogens, Non-Steroidal - pharmacology</topic><topic>Flavonoids - pharmacology</topic><topic>Foods and miscellaneous</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Imidazoles - metabolism</topic><topic>inhibition</topic><topic>Isoflavones</topic><topic>liver</topic><topic>Liver Neoplasms - chemically induced</topic><topic>Liver Neoplasms - metabolism</topic><topic>Liver Neoplasms - prevention & control</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>microsomes</topic><topic>Microsomes, Liver - drug effects</topic><topic>Microsomes, Liver - metabolism</topic><topic>Phenols - pharmacology</topic><topic>Phytoestrogens</topic><topic>Plant Preparations</topic><topic>Polymers - pharmacology</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hammons, G.J</creatorcontrib><creatorcontrib>Fletcher, J.V</creatorcontrib><creatorcontrib>Stepps, K.R</creatorcontrib><creatorcontrib>Smith, E.A</creatorcontrib><creatorcontrib>Balentine, D.A</creatorcontrib><creatorcontrib>Harbowy, M.E</creatorcontrib><creatorcontrib>Kadlubar, F.F</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Nutrition and cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hammons, G.J</au><au>Fletcher, J.V</au><au>Stepps, K.R</au><au>Smith, E.A</au><au>Balentine, D.A</au><au>Harbowy, M.E</au><au>Kadlubar, F.F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes</atitle><jtitle>Nutrition and cancer</jtitle><addtitle>Nutr Cancer</addtitle><date>1999</date><risdate>1999</risdate><volume>33</volume><issue>1</issue><spage>46</spage><epage>52</epage><pages>46-52</pages><issn>0163-5581</issn><eissn>1532-7914</eissn><coden>NUCADQ</coden><abstract>Carcinogenic aromatic amines, including the heterocyclic amines, may pose a significant health risk to humans. To determine the potential for chemoprotective intervention against the carcinogenicity of these arylamines and to better understand their mechanism of action, a range of agents, most of them natural dietary constituents, was examined in vitro for their ability to modulate the N-hydroxylation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 4-aminobiphenyl (ABP), an initial step in their bioactivation. Experiments were conducted with rat and human liver microsomes. The agents (diallyl sulfide, indole-3-carbinol, alpha-angelicalactone, cafestol/kahweol palmitates, cafestol, kahweol, benzylisothiocyanate, genistin, formononetin, daidzin, equol, biochanin A, Oltipraz, tannic acid, quercetin, ethoxyquin, green tea, and black tea) comprised a variety of chemical classes that included sulfur-containing compounds, antioxidants, flavonoids, phytoestrogens, diterpenes, and polyphenols. Several of these agents, quercetin, ethoxyquin, and black tea, were found to strongly inhibit PhIP N-hydroxylation in rat liver microsomes, resulting in a nearly 85-90% decrease in activity at 100 micromolar or 0.2%. Tannic acid and green tea, in addition to these agents, were also strong inhibitors of ABP N-hydroxylation. In human liver microsomes, each of these agents was strongly inhibitory (approx 85-95% at 100 micromolar or 0.02%) of PhIP and ABP N-hydroxylation. Theaflavins and polyphenols were judged to be the primary inhibiting components in the teas, the theaflavins showing the most potent effect. These results demonstrate that chemoprotective agents can inhibit the bioactivation of carcinogenic arylamines, and this is likely to be one of the mechanisms of protection.</abstract><cop>Philadelphia, PA</cop><pub>Taylor & Francis Group</pub><pmid>10227043</pmid><doi>10.1080/01635589909514747</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-5581 |
ispartof | Nutrition and cancer, 1999, Vol.33 (1), p.46-52 |
issn | 0163-5581 1532-7914 |
language | eng |
recordid | cdi_fao_agris_US201302935996 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | amines Aminobiphenyl Compounds - metabolism animal models Animals Anticarcinogenic Agents - pharmacology antineoplastic agents Antioxidants - pharmacology aromatic compounds Biological and medical sciences Carcinogenesis, carcinogens and anticarcinogens carcinogens Carcinogens - metabolism Diterpenes - pharmacology Estrogens, Non-Steroidal - pharmacology Flavonoids - pharmacology Foods and miscellaneous Gastroenterology. Liver. Pancreas. Abdomen Humans Imidazoles - metabolism inhibition Isoflavones liver Liver Neoplasms - chemically induced Liver Neoplasms - metabolism Liver Neoplasms - prevention & control Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences microsomes Microsomes, Liver - drug effects Microsomes, Liver - metabolism Phenols - pharmacology Phytoestrogens Plant Preparations Polymers - pharmacology Rats Rats, Inbred F344 Tumors |
title | Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T05%3A46%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_fao_a&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20chemoprotective%20agents%20on%20the%20metabolic%20activation%20of%20the%20carcinogenic%20arylamines%20PhIP%20and%204-aminobiphenyl%20in%20human%20and%20rat%20liver%20microsomes&rft.jtitle=Nutrition%20and%20cancer&rft.au=Hammons,%20G.J&rft.date=1999&rft.volume=33&rft.issue=1&rft.spage=46&rft.epage=52&rft.pages=46-52&rft.issn=0163-5581&rft.eissn=1532-7914&rft.coden=NUCADQ&rft_id=info:doi/10.1080/01635589909514747&rft_dat=%3Cpubmed_fao_a%3E10227043%3C/pubmed_fao_a%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/10227043&rfr_iscdi=true |